FRONT ENDOCRINOL
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q1 | 35/198 |
82.3%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q2 | 55/161 JCI 0.87 |
66.5%
|
Frontiers in Endocrinology (FRONT ENDOCRINOL, ISSN: 1664-2392) is a leading peer-reviewed, open-access journal dedicated to advancing knowledge across the full spectrum of endocrinological science. Published by Frontiers Media SA, the journal covers fundamental, translational, and clinical research, encompassing topics such as hormone signaling, metabolic disorders, neuroendocrinology, reproductive endocrinology, diabetes, thyroid and adrenal biology, bone and mineral metabolism, and endocrine-related cancers. The journal welcomes a diverse array of article types, including original research articles, comprehensive reviews, mini-reviews, clinical trials, systematic reviews, methods, perspectives, and case reports, ensuring broad dissemination of both novel findings and critical syntheses. Its target audience comprises academic researchers, clinical endocrinologists, metabolic disease specialists, physiologists, pharmacologists, and healthcare professionals seeking cutting-edge insights into hormonal regulation and endocrine pathophysiology. A notable feature is its rigorous, collaborative peer-review process combined with a fully open-access model, which maximizes the visibility and impact of published work by removing subscription barriers. With a 2026 Journal Citation Reports Impact Factor of 5.7000 and placement in the Q1 quartile of its category, Frontiers in Endocrinology is recognized as a high-tier, influential venue in the field. This standing reflects its strong citation performance and consistent contribution to shaping contemporary endocrine research, making it an essential resource for the global scientific community.